g operations, (4) changes in the regulatory
environment in which the Company operates, (5) changes in worldwide tax
rates or tax benefits from domestic and international operations, including
the matters described in Note 4 to the Consolidated Financial Statements -
Uncertainty in Income Taxes - in the Company's Form 10-Q report for the
quarter ended June 30, 2007, (6) exposure to litigation, including product
liability claims, (7) changes in research funding and the success of
research and development activities, (8) the ability to maintain adequate
quality standards, (9) reliance on third party package delivery services,
(10) the impact of acquisitions and success in integrating and obtaining
projected results from the acquisitions, (11) other changes in the business
environment in which the Company operates, and (12) the outcome of the
matters described in Note 13 to the Consolidated Financial Statements -
Contingent Liabilities and Commitments - in the Company's Form 10-Q report
for the quarter ended June 30, 2007. A further discussion of the Company's
risk factors can be found in Item 1A of the Company's Form 10-K report for
the year ended December 31, 2006. The Company does not undertake any
obligation to update these forward- looking statements.
SIGMA-ALDRICH CORPORATION
Consolidated Statements of Income (Unaudited)
(in millions except per share amounts)
Three Months Ended Nine Months Ended
September 30, September 30,
2007 2006 2007 2006
Net sales $503.2 $441.4 $1,506.6 $1,333.0
Cost of products sold 247.3 218.7 735.8 647.0
Gross profit 255.9 222.7 770.8 686.0
Selling, general and administrative
expenses
'/>"/>
SOURCE Sigma-Aldrich Copyright©2007 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Related biology technology :1.
Jellyfish partners for sales tracking technology2.
Doyle wants sales tax applied to digital downloads3.
Mortgagebot builds online sales even as housing declines4.
Third Wave reports another loss, stronger sales5.
Johnson Controls reports record quarterly sales6.
Can sales outsourcing grow Wisconsin biotechs?7.
Sonic Foundry reports quarterly loss, higher Mediasite sales8.
My-oh, its BIO! Where sales hype and science collide9.
Third Wave shuffles finance, sales management10.
Johnson Controls sales up, profits down11.
Turning ads into sales: Context is king